Join today and be a part of the fastest growing B2B Network Join Now

TOFACITINIB CITRATE

  • Origin: China

Supplier Info.

  • Employees Total 51-100
  • Annual Revenue US$1 Million - US$2.5 Million
Product name:TOFACITINIB CITRATE CAS:540737-29-9 Appearance:Unstable oil Assay: 99% Chemical name: (3R,4R)-1-(Cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo[2,3-d]pyrimidin-4-yl-3-piperidinamine 2-hydroxy-1,2,3-propanetricarboxylate By name: CP-690550 Description Tofacitinib, an inhibitor of Janus kinases (JAKs), is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate. It may be used as monotherapy or in combination with methotrexate or other nonbiologic disease-modifying antirheumatic drugs (DMARDs). Tofacitinib should not be used in combination with biologic DMARDs or potent immunosuppressants such as azathioprine and cyclosporine.
Premium Services
Tell us your Requirement
Girl Right
Cross Popup
Arrow 2

I Am :

Signup today to claim your Discount. Get Started before it's too late!

Arrow 1
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Ok